Foghorn Therapeutics (FHTX) Cash & Equivalents (QoQ) (2019 - 2026)
Foghorn Therapeutics (FHTX) Cash & Equivalents (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.75 Bn | 467.96 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.14 Bn | 114.89 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn |
| 10 | Foghorn Therapeutics | 355.00 Mn | 266.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.39% |
| Dec 31, 2025 | -9.47% |
| Sep 30, 2025 | 23.10% |
| Jun 30, 2025 | 18.92% |
| Mar 31, 2025 | 10.05% |
| Dec 31, 2024 | -3.86% |
| Sep 30, 2024 | -58.49% |
| Jun 30, 2024 | 75.32% |
| Mar 31, 2024 | -1.35% |
| Dec 31, 2023 | 14.27% |
| Sep 30, 2023 | 21.84% |
| Jun 30, 2023 | 13.95% |
| Mar 31, 2023 | -3.01% |
| Dec 31, 2022 | -40.40% |
| Sep 30, 2022 | 43.13% |
| Jun 30, 2022 | -71.35% |
| Mar 31, 2022 | 111.25% |
| Dec 31, 2021 | 74.85% |
| Sep 30, 2021 | -53.79% |
| Jun 30, 2021 | 88.36% |